Correlation of expression of Ki-67, EGFR, c-erbB-2, MMP-9, p53, bcl-2, CD34 and cell cycle analysis with survival in head and neck squamous cell cancer

Journal of Experimental and Clinical Cancer Research

Volumn 25, Issue 4, 2006, Pages 549-555

  Smilek, Pavel ^a   Dusek L ^a   Vesely K ^a   Rottenberg, J ^a   Kostrica R ^a  

^a ST ANNE S UNIVERSITY HOSPITAL   (Czech Republic)

Author keywords

bcl 2; DNA cytometry; Head neck cancer; Mitotic index

Indexed keywords

CD34 ANTIGEN; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; GELATINASE B; KI 67 ANTIGEN; PROTEIN BCL 2; PROTEIN P53;

ADULT; AGED; APOPTOSIS; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CELL CYCLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA DETERMINATION; FEMALE; FLOW CYTOMETRY; HEAD AND NECK CANCER; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MITOSIS; OVERALL SURVIVAL; PLOIDY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; RISK FACTOR; SCORING SYSTEM; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD; ANTIGENS, CD34; CARCINOMA, SQUAMOUS CELL; CELL CYCLE; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; KI-67 ANTIGEN; MALE; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; NEOPLASM STAGING; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTOR, EPIDERMAL GROWTH FACTOR; SURVIVAL ANALYSIS; TREATMENT OUTCOME; TUMOR SUPPRESSOR PROTEIN P53;

EID: 33846549366     PISSN: 03929078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Lefebvre J.L: Current clinical outcomes demand new treatment options for SCCHN. Annals of Oncology, 16 (Supplement 6): vi7-vi12, 2005.
2. Altman D.G.: Practical Statistics for Medical Research. London: Chapman and Hall, 199, 619p.
3. Boran C., Yildiz L., Kandemir B., Karagoz F., Baris S., Aydin O.: Correlation of proliferating cell nuclear antigen and bcl-2 expression with tumor front grading and metastasis in laryngeal squamous cell carcinoma. Neoplasma 50: 139-143, 2003.
4. Cabelguenne A., Blons H., de Waziers I., Carnot F. et al.: P53 Alterations Predict Tumor Response to Neoadjuvant Chemotherapy in Head and Neck Squamous cell Carcinoma: A Prospective Series. Journal of Clinical Oncology 18: 1465-1473, 2000.
5. Costa A., Licitra L., Veneroni S. et al.: Biological markers as indicators of pathological response to primary chemotherapy in oral-cavity cancers. Int. J. Cancer (Pred. Oncol.) 79: 619-623, 1998.
6. Dray T.G., Hardin N.J., Sofferman R.A.: Angiogenesis as a prognostic marker in early head and neck cancer. Ann. Otol. Rhinol. Laryngol. 104:724-729, 1995.
7. Kearsley J.H., Thomas S.: Prognostic markers in cancers of the head and neck region. Anti-Cancer Drugs 4: 419-429, 1993.
8. Georgolios A., Batistatou A., Manolopoulos L., Charalabopoulos K.: Role and Expression Patterns of E-Cadherin in Head and Neck Squamous Cell Carcinoma (HNSCC). J. Exp. Clin. Cancer Res. 25: 5-14, 2006.
9. Horii A., Yoshida J., Sakai M., Okamoto S., Kubo T.: Flow cytometric analysis of DNA content and Ki-67 fractions in the diagnosis of salivary gland tumors. Eur. Arch. Otorhinolaryngol. 255: 265-268, 1998.
10. Bueno R.P., Gias N.L., Delgado G.R., Cebollada D.J., Gonzales F.J.: Tumor DNA content as a prognostic indicator in squamous cell carcinoma of the oral cavity and tongue base. Head Neck 20(3): 232-239, 1998.
11. Ispizua A., Baroja A., de la Hoz C.: Correlation of DNA content of laryngeal epithelial lesions to degree of malignancy. Journal of Clinical Oncology 12: 1600-1606, 1994.
12. Acikalin M.F., Oner U., Pasaoglu N.T.O., Cakli H., Colak E.: Prognostic significance of Ki-67 expression for patients with laryngeal squamous cell carcinoma primarily treated by total laryngectomy. Eur. Arch. Otorhinolaryngol. 261: 376-380, 2004.
13. Lavertu P., Adelstein D.J., Myles J., Secic M.: P53 and Ki-67 as Outcome Predictors for Advanced Squamous Cell Cancers of the Head and Neck Treated with chemoradiotherapy. Laryngoscope 111: 1878-1892, 2001.
14. Noguchi M., Kinjyo H., Miyazaki A., Kubota H., Kohama G.: Control of cell proliferation kinetic of tumor in neoadjuvant chemotherapy for advanced oral squamous cell carcinoma and its prognostic implications. Int. J. Clin. Oncol. 7: 138-144, 2002.
15. Jäckel M.C., Sellmann L., Dorudian M.A., Yousssef S., Fuzesi L.: Prognostic Significance of p53/Bcl-2 Co-expression in Patients With Laryngeal Squamous Cell Carcinoma: Laryngoscope 110: 1339-1345, 2000.
16. Myers E.N., Suen J.Y., Myers J.N., Hanna E.Y.N.: Cancer of the Head and Neck. Philadelphia: Elseviere Science, Saunders, 2003, 850 p.
17. Ikebe T., Shinohara M., Takeuchi H. et al.: Gelatinolytic activity of matrix metalloproteinase in tumor tissues correlates with the invasiveness of oral cancer. Clin. Exp. Metastasis. 17(4): 315-23, 1999.
18. Arteaga C.L.: Epidermal growth Factor Receptor Dependence in Human Tumors: More than Just Expression? The Oncologist, 7, suppl 4: 31-39, 2002.
19. Mrhalova M., Plzák J., Betka J., Kodet R.: Epidermal growth factor receptor - its expression and copy numbers of EGFR gene in patients with head and neck squamous cell carcinomas. Neoplasma 52: 338-343, 2005.
20. Schartinger V.H., Kacani L., Andrle J. et al.: Pharmacodiagnostic Value of the HER Family in Head and Neck Squamous Cell Carcinoma. ORL 66: 21-26, 2004.
21. Albuquerque R.L. Jr, Miguel M.C., Costa A.L., Souza L.B.: Correlation of c-erbB-2 and S-100 expression with the malignancy grading and anatomical site in oral squamous cell carcinoma. Int. J. Exp. Pathol. 84(6): 259-265, 2003.
22. Klatka J.: Prognostic value of the expression of p53 and bcl-2 in patients with laryngeal carcinoma. Eur. Arch. Otorhinolaryngol. 258: 537-541, 2001.
23. Sittel C.H., Eckel H.E., Damm M., Pritzbuer E., Kvasnicka H.M.: Ki-67 (MIB 1), p53, and Lewis-X (LeuM 1) as Prognostic Factors of Recurrence in T1 and T2 Laryngeal Carcinoma. Laryngoscope 110: 1012-1017, 2000.
24. Temam S., Flahault A., Périé S. et al.: P53 Gene Status as a Predictor of Tumor Response to induction Chemotherapy of Patiens with Locoregionally Advanced Squamous Cell Carcinomas of the Head and Neck. Journal of Clinical Oncology 18: 385-390, 2000.
25. Vielba R., Bilbao J., Ispizua A. et al.: P53 and Cyclin D1 as Prognostic Factors in Squamous Cell Carcinoma of the Larynx. Laryngoscope 113: 167-172, 2003.